ERIS LIFESCIENCES LIMITED (ERIS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.[1]

ERISUpdated 29 Aug 2026, 2:33

Eris Lifesciences Limited

Market Cap

₹18,229Cr.

Current Price

₹1,315

High / Low

₹1,811/1,200

Stock P/E

88.4

ROE8.89%
ROCE11.1%
Book Value₹231
Face Value₹1.00
Dividend Yield0.55%

About

ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days161521293150374163595162
Inventory Days1811561611942061451191559811914071
Days Payable1218886266207200159177128143158128
Cash Conversion Cycle758497-4330-4-3193335334
Working Capital Days138312-2258658052-413-99-145
ROCE %44%53%62%35%26%24%27%27%20%10%7%11%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:33


Designed & Shipped by Harshit Bansal